PROTEOSTASIS THERAPEUTICS IN's ticker is PTI and the CUSIP is 74373B109. A total of 51 filers reported holding PROTEOSTASIS THERAPEUTICS IN in Q2 2020. The put-call ratio across all filers is 2.01 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $297,000 | -32.2% | 270,000 | -15.6% | 0.01% | -22.2% |
| Q2 2020 | $438,000 | +219.7% | 320,000 | +166.7% | 0.01% | +200.0% |
| Q1 2020 | $137,000 | -50.0% | 120,000 | 0.0% | 0.00% | -25.0% |
| Q4 2019 | $274,000 | +171.3% | 120,000 | 0.0% | 0.00% | +300.0% |
| Q3 2019 | $101,000 | 0.0% | 120,000 | +50.0% | 0.00% | 0.0% |
| Q1 2019 | $101,000 | -61.0% | 80,000 | 0.0% | 0.00% | -66.7% |
| Q4 2018 | $259,000 | -22.7% | 80,000 | -42.4% | 0.00% | 0.0% |
| Q3 2018 | $335,000 | -13.4% | 138,845 | 0.0% | 0.00% | -25.0% |
| Q2 2018 | $387,000 | -41.4% | 138,845 | 0.0% | 0.00% | -42.9% |
| Q1 2018 | $660,000 | -18.8% | 138,845 | -0.5% | 0.01% | -22.2% |
| Q4 2017 | $813,000 | +253.5% | 139,500 | +27.4% | 0.01% | +200.0% |
| Q3 2017 | $230,000 | -17.3% | 109,500 | +84.0% | 0.00% | 0.0% |
| Q2 2017 | $278,000 | – | 59,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VHCP Management III, LLC | 848,610 | $2,749,000 | 2.00% |
| GREAT POINT PARTNERS LLC | 3,045,423 | $9,867,000 | 1.25% |
| NEA Management Company, LLC | 5,556,778 | $18,004,000 | 0.71% |
| VHCP Management II, LLC | 501,390 | $1,625,000 | 0.70% |
| SECTORAL ASSET MANAGEMENT INC | 1,581,728 | $5,125,000 | 0.70% |
| HARBOURVEST PARTNERS LLC | 440,627 | $1,428,000 | 0.68% |
| EAM Investors, LLC | 596,871 | $1,934,000 | 0.52% |
| EAM Global Investors LLC | 252,778 | $819,000 | 0.45% |
| Avoro Capital Advisors LLC | 1,300,000 | $4,212,000 | 0.25% |
| Ghost Tree Capital, LLC | 190,000 | $616,000 | 0.22% |